Study demonstrated inhibiting phosphodiesterase-1 with ITI-214 in patients with heart failure improved cardiac function by enhancing cardiac contractility and dilating […]
U.S. Flatbed Carrier Acquisition Further Strengthens TFI’s U.S. Specialized Truckload OperationsEnhances Ability to Serve TFI’s Canadian Flatbed Group Customers in […]
WARREN, N.J., June 29, 2020 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company focused on developing […]